Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status

INTRODUCTION: We evaluated for two novel automated biomarker assays how cerebrospinal fluid (CSF) amyloid beta (Aβ)(1– 42)‐ratios improved the concordance with amyloid positron emission tomography (PET) positivity compared to Aβ(1– 42) alone. METHODS: We selected 288 individuals from the Amsterdam D...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (Amst)
Autores principales: Willemse, Eline A. J., Tijms, Betty M., van Berckel, Bart N. M., Le Bastard, Nathalie, van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cerebrospinal Fluid Biomarkers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088096/
https://ncbi.nlm.nih.gov/pubmed/33969174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12182
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares